Chris Spivey

Chris Spivey is the editorial director of BioPharm International.


Pedestrians as Priority

Coverage of COVID-19 vaccines was surprisingly displaced by this year’s astounding oncology and iconoclastic gene therapy “cures.”

mRNA Hauptbahnhof

mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.

Conference Time Brings Gifts

Content is king in publishing, but interpretation is imperator.

Industry’s Best Secret

One can only learn the secrets of "fight club" by attending its meetings.

Vaccine Disconnect

More than anything else MonkeyPox and COVID-19 have shown that we are interdependent, no matter what continent you call home.

Navigating the Future

Promising applications for targeted delivery may be cresting the horizon.

Process Development Struggles with Molecular Diversity

As we reach further afield in the molecular universe, we encounter new types of problems to resolve.

The Next Pandemic

Lions and tigers and monkeypox, oh my!